NSE · Healthcare · Diagnostics & Research
EPS came in at 1.58 against a street estimate of 1.50 — a beat of 5.3%.
| Document | Date |
|---|---|
| Q1 FY27 earnings call VIMTA LABS LIMITED - Q1 FY'27 EARNINGS CALL SUMMARY HEADLINE NUMBERS • Total Income Q1 FY27: INR 1,129 million, up 13.7% year-on-year (Q1 FY26: INR | 2026-07-24 |
| Investor presentation · Q1 FY27 VIMTA LABS LTD - Q1 FY27 INVESTOR SUMMARY HEADLINE NUMBERS • Total Income: Rs 1,129 Mn (11.1% YoY growth from Rs 993 Mn in Q1 FY26) • EBITDA: Rs 411 | 2026-07-20 |
| Quarterly results · Q1 FY27 VIMTA LABS LIMITED – Q1 FY2026-27 FINANCIAL SUMMARY HEADLINE NUMBERS • Revenue from operations (Q1 FY26-27): INR 1,090.74 million (vs. INR 1,092.45 | 2026-07-20 |
| Annual report FY2026 VIMTA LABS LIMITED - ANNUAL REPORT FY 2025-26 SUMMARY HEADLINE NUMBERS • Revenue from Operations: INR 4,072.90 million (FY 2026) vs INR 3,439.82 mil | 2026-06-01 |
| Q4 FY26 earnings call VIMTA LABS LIMITED – Q4 FY '26 EARNINGS CALL SUMMARY HEADLINE NUMBERS • Q4 FY '26 Total Income: INR1,120 million vs INR961 million in Q4 FY '25, up | 2026-05-12 |
| Quarterly results · Q4 FY26 VIMTA LABS LIMITED – FINANCIAL RESULTS SUMMARY (FY26) HEADLINE NUMBERS • FY26 Total Revenue: Rs. 4,163 Million – up 19.5% year-on-year from Rs. 3,48 | 2026-05-06 |
| Investor presentation VIMTA LABS LTD - INVESTOR SUMMARY HEADLINE NUMBERS • FY26 Total Income: Rs 4,163 Mn (up 19.5% YoY from Rs 3,482 Mn in FY25) • FY26 PAT (Profit After | 2026-05-06 |
| Q3 FY26 earnings call VIMTA LABS LIMITED – Q3 FY'26 EARNINGS CALL SUMMARY HEADLINE NUMBERS • Q3 FY'26 Revenue: INR 100.5 crores (INR 1,005 million), up 10.2% year-on-year | 2026-02-03 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹2 / share ex-date Jun 18, 2026 | 2026-06-18 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Vimta Labs Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.